Sunesis Pharmaceuticals Inc. announced that the European Commission has granted orphan drug designation to vosaroxin for the treatment of acute myeloid leukemia.
Genentech announced that the SUMMACTA study met its primary endpoint, showing comparable efficacy of subcutaneous Actemra to intravenous Actemra.
A University of Iowa researcher will square off against the nonprofit group that manages the school's intellectual property in a high-stakes trial over potential arthritis treatments.
Irish drugmaker Warner Chilcott PLC turned a first-quarter profit as several expenses fell and sales growth for the drug Asacol helped counter a drop from the osteoporosis treatment Actonel.
The world's largest drugmaker, Pfizer, halted a late-stage study of its second-best selling drug, Lyrica, as a possible treatment for a nerve pain in HIV patients.
Endo Pharmaceuticals turned a first-quarter loss after absorbing a $110-million pre-tax charge connected to a settlement and license agreement with Impax Laboratories Inc.
Protea Biosciences Group Inc. announced the opening of its 10,000 sq. ft. laboratory services facility in Morgantown, West Virginia.
Johnson & Johnson' Chinese investment entity bought Guangzhou Bioseal Biotechnology Co., a company that makes a plasma product used to control bleeding during surgery.
An extra copy of a brain-development gene, which appeared in our ancestors’ genomes about 2.4 million years ago, allowed maturing neurons to migrate farther and develop more connections.
Infants born to women who used the anti-HIV drug tenofovir during pregnancy do not weigh less at birth and are not of shorter length than infants born to women do not.
NovaBay Pharmaceuticals Inc. announced data demonstrating that resistance to its lead compound, NVC-422, is highly unlikely for a variety of infectious organisms.
The first randomized controlled trial to assess the effectiveness of memantine, a drug prescribed for Alzheimer's disease, showed the drug does not ease clinically significant agitation in patients.
Abbott Laboratories will spend $110 million to buy a potential kidney treatment from the privately held Danish company Action Pharma, the company said.
Authorities have made arrests in the 2010 theft of about $80 million in prescription drugs, a robbery described as one of the biggest pharmaceutical heists in history.